[:fr]Actualités[:]

[:fr]

Presse

2017

2012

Publications

2017

  • Fritel X, van den Heuvel E, Wagg A, Lavoie M, Le Gall A, Ragot S, Tannenbaum C
    Continence across continents to upend stigma and dependency (CACTUS-D): preliminary results of an international randomized controlled trial of a continence promotion intervention.

2015

  • Sosner P, Hulin-Delmotte C, Saulnier PJ, Cabasson S, Gand E, Torremocha F, Piguel X, Miot A, Maréchaud R, Herpin D, Ragot S, Hadjadj S;
    SURDIAGENE Study Group. Cardiovascular prognosis in patients with type 2 diabetes: Contribution of heart and kidney subclinical damage.
    Am Heart J.
  • Frat JP, Brugiere B, Ragot S, Chatellier D, Veinstein A, Goudet V, Coudroy R, Petitpas F, Robert R, Thille AW, Girault C.
    Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study.
    Respir Care
  • Dompeyre P, Fritel X, Fauconnier A, Robain G
    Pelvic floor muscle contraction and maximum urethral closure pressure 
    Prog Urol
  • Blond S, Mertens P, David R, Roulaud M, Rigoard P.
    From « mechanical » to « neuropathic » back pain concept in FBSS patients. A systematic review based on factors leading to the chronification of pain (part C).
    Neurochirurgie
  • Jaafari N, Chopin N, Levy C, Rotgé JY, Lafay N, Hammi W, Rigalleau F, Millet B, Krebs MO, Vibert N; Insight Study Group.
    Excessive checking behavior during an image comparison task in schizophrenia.
    Eur Psychiatry
  • Fritel X
    Urodynamic testing before stress-incontinence surgery in women: cost-effectiveness analysis and ethical considerations 
    Prog Urol.
  • Hijiya N, Millot F, Suttorp M.
    Chronic myeloid leukemia in children: clinical findings, management, and unanswered questions. Pediatr Clin North Am.
  • Jayle CP, Allain G, Ingrand P, Laksiri L, Bonnin E, Hajj-Chahine J, Mimoz O, Corbi P. Flail chest in polytraumatized patients: surgical fixation using Stracos reduces ventilator time and hospital stay. Biomed Res Int.
  • Julian A, Dugast E, Ragot S, Krolak-Salmon P, Berrut G, Dantoine T, Hommet C, Hanon O, Page G, Paccalin M.
    There is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer’s disease.
    Aging Clin Exp Res
  • Hirsch C, Breque C, Ragot S, Pascal-Mousselard H, Richer JP, Scepi M, Khiami F. Biomechanical study of dynamic changes in L4-L5 foramen surface area in flexion and extension after implantation of four interspinous process devices.
    Orthop Traumatol Surg Res.
  • Hoffmann VS, Baccarani M, Hasford J, Lindoerfer D, Burgstaller S, Sertic D, Costeas P, Mayer J, Indrak K, Everaus H, Koskenvesa P, Guilhot J, Schubert-Fritschle G, Castagnetti F, Di Raimondo F, Lejniece S, Griskevicius L, Thielen N, Sacha T, Hellmann A, Turkina AG, Zaritskey A, Bogdanovic A, Sninska Z, Zupan I, Steegmann JL, Simonsson B, Clark RE, Covelli A, Guidi G, Hehlmann R.
    The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.
    Leukemia
  • Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group.
    Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson’s disease.
    Brain
  • Guilhot J, Preudhomme C, Mahon FX, Guilhot F. Analyzing molecular response in chronic myeloid leukemia clinical trials: pitfalls and golden rules.
    Cancer.
  • Arroyo-Anlló EM, Ingrand P, Neau JP, Gil R.
    Procedural learning of semantic categorization in Parkinson’s disease.
    J Alzheimers Dis.
  • Rieu I, Martinez-Martin P, Pereira B, De Chazeron I, Verhagen Metman L, Jahanshahi M, Ardouin C, Chéreau I, Brefel-Courbon C, Ory-Magne F, Klinger H, Peyrol F, Schupbach M, Dujardin K, Tison F, Houeto JL, Krack P, Durif F.
    International validation of a behavioral scale in Parkinson’s disease without dementia
    Mov Disord.
  • Godet C, Goudet V, Laurent F, Le Moal G, Gounant V, Frat JP, Cateau E, Roblot F, Cadranel J. Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
    Mycoses
  • Vilaplana M, Richard-Devantoy S, Turecki G, Jaafari N, Jollant F.
    J Clin Psychiatry. »
  • Contou D, Coudroy R, Thille AW
    Acute Hypercapnic Respiratory Failure Due to Exacerbation of Chronic Obstructive Pulmonary Disease: Who Are the Patients Most at Risk for Intubation? 
    Crit Care Med
  • Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JC, Brochard L, Robert R;
    FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.
    N Engl J Med
  • Halme AS, Fritel X, Benedetti A, Eng K, Tannenbaum C.
    Implications of the minimal clinically important difference for health-related quality-of-life outcomes: a comparison of sample size requirements for an incontinence treatment trial.
    Value Health
  • Coudroy R, Jamet A, Thille AW.
    Is skin mottling a predictor of high mortality in non-selected patients with cirrhosis admitted to intensive care unit?
    J Hepatol.
  • Pizza F, Jaussent I, Lopez R, Pesenti C, Plazzi G, Drouot X, Leu-Semenescu S, Beziat S, Arnulf I, Dauvilliers Y.
    Car Crashes and Central Disorders of Hypersomnolence: A French Study.
    PLoS One
  • Clappier E, Grardel N, Bakkus M, Rapion J, De Moerloose B, Kastner P, Caye A, Vivent J, Costa V, Ferster A, Lutz P, Mazingue F, Millot F, Plantaz D, Plat G, Plouvier E, Poirée M, Sirvent N, Uyttebroeck A, Yakouben K, Girard S, Dastugue N, Suciu S, Benoit Y, Bertrand Y, Cavé H.
    IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children’s Leukemia Group study 58951.
    Leukemia
  • Bonnefond A, Lamri A, Leloire A, Vaillant E, Roussel R, Lévy-Marchal C, Weill J, Galan P, Hercberg S, Ragot S, Hadjadj S, Charpentier G, Balkau B, Marre M, Fumeron F, Froguel P.
    Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels.
    J Med Genet
  • Bridoux A, Créange A, Sangare A, Ayache SS, Hosseini H,Drouot X, Lefaucheur JP.
    Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
    J Neurol Sci.
  • Velho G, Ragot S, Mohammedi K, Gand E, Fraty M, Fumeron F,Saulnier PJ, Bellili-Munoz N, Bouby N, Potier L, Alhenc-Gelas F, Marre M, Hadjadj S, Roussel R.
    Plasma adrenomedullin, allelic variation in the ADM gene and kidney disease in people with type 2 diabetes.
    Diabetes
  • Thille AW, Roche-Campo F, Brochard L.
    Ten reasons to be more attentive to patients when setting the ventilator.
    Intensive Care Med
  • Thubert T, Bakker E, Fritel X.
    Pelvic floor muscle training and pelvic floor disorders in women. 
    Gynecol Obstet Fertil
  • Fritel X
    Outbreak of caesarean sections and fear of birth injury.
    Gynecol Obstet Fertil
  • Brunault P, Salamé E, Jaafari N, Courtois R, Réveillère C, Silvain C, Benyamina A, Blecha L, Belin D, Ballon N.
    Why do liver transplant patients so often become obese? The addiction transfer hypothesis.
    Med Hypotheses
  • Legras A, Caille A, Begot E, Lhéritier G, Lherm T, Mathonnet A,Frat JP, Courte A, Martin-Lefèvre L, Gouëllo JP, Mercier E, Vignon P; ARCO and CRICS network. Acute respiratory distress syndrome (ARDS)-associated acute cor pulmonale and patent foramen ovale: a multicenter noninvasive hemodynamic study. Crit Care
  • Lascarrou JB, Meziani F, Le Gouge A, Boulain T, Bousser J, Belliard G, Asfar P, Frat JP, Dequin PF, Gouello JP, Delahaye A, Hssain AA, Chakarian JC, Pichon N, Desachy A, Bellec F, Thevenin D, Quenot JP, Sirodot M, Labadie F, Plantefeve G, Vivier D, Girardie P, Giraudeau B, Reignier J; Clinical Research in Intensive Care and Sepsis (CRICS) Group and HYPERION Study Group.
    Therapeutic hypothermia after nonshockable cardiac arrest: the HYPERION multicenter, randomized, controlled, assessor-blinded, superiority trial.
    Scand J Trauma Resusc Emerg Med
  • Coudroy R, Jamet A, Peñuelas O, Thille AW.
    Use of Type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliferative therapy?
    Intensive Care Med
  • Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandière M, Kipnis E, Vela C, Chevallier S, Mallat J, Robert R; ABDOMIX Group.
    Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
    Intensive Care Med
  • Boissier F, Razazi K, Thille AW, Roche-Campo F, Leon R, Vivier E, Brochard L, Brun-Buisson C, Mekontso Dessap A.
    Echocardiographic detection of transpulmonary bubble transit during acute respiratory distress syndrome.
    Ann Intensive Care
  • Mohammedi K, Bellili-Muñoz N, Marklund SL, Driss F, Le Nagard H, Patente TA, Fumeron F, Roussel R,Hadjadj S, Marre M, Velho G.
    Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
    Cardiovasc Diabetol
  • Vilaplana M, Richard-Devantoy S, Turecki G, Jaafari N, Jollant F.
    Insight into mental disorders and suicidal behavior: a qualitative and quantitative multimodal investigation.
    J Clin Psychiatry.
  • Nicolas A, Fatima S, Lamri A, Bellili-Muñoz N, Halimi JM, Saulnier PJ, Hadjadj S, Velho G, Marre M, Roussel R, Fumeron F.
    ABCG8 polymorphisms and renal disease in type 2 diabetic patients.
    Metabolism.
  • Millot F, Suttorp M.
    Managing children with chronic myeloid leukaemia – response to baccarani.
    Br J Haematol
  • Thille AW, Vuylsteke A, Bersten A.
    Does the Berlin definition for acute respiratory distress syndrome predict the presence of diffuse alveolar damage?
    Intensive Care Med
  • Coudroy R, Jamet A, Frat JP, Veinstein A, Chatellier D, Goudet V, Cabasson S, Thille AW, Robert R.
    Incidence and impact of skin mottling over the knee and its duration on outcome in critically ill patients.
    Intensive Care Med
  • Bridoux A, Drouot X, Sangare A, Al-Ani T, Brignol A, Charles-Nelson A, Brugières P, Gouello G, Hosomi K, Lepetit H, Palfi S.
    Bilateral thalamic stimulation induces insomnia in patients treated for intractable tremor.
    Sleep
  • Thille AW, Boissier F, Ben Ghezala H, Razazi K, Mekontso-Dessap A, Brun-Buisson C.
    Risk factors for and prediction by caregivers of extubation failure in ICU patients: a prospective study.
    Crit Care Med.
  • Roulaud M, Durand-Zaleski I, Ingrand P, Serrie A, Diallo B, Peruzzi P, Hieu PD, Voirin J, Raoul S, Page P, Fontaine D, Lantéri-Minet M, Blond S, Buisset N, Cuny E, Cadenne M, Caire F, Ranoux D, Mertens P, Naous H, Simon E, Emery E, Gadan B, Regis J, Sol JC, Béraud G, Debiais F, Durand G, Guetarni Ging F, Prévost A, Brandet C, Monlezun O, Delmotte A, d’Houtaud S, Bataille B, Rigoard P.
    Multicolumn spinal cord stimulation for significant low back pain in failed back surgery syndrome: design of a national, multicentre, randomized, controlled health economics trial (ESTIMET Study).
    Neurochirurgie
  • Jégu M, Some Der A, Morcel K, Abadie C, Fritel X, Levêque J.
    Breast and ovarian cancer due to BRCA1&2 hereditary cancer predisposition syndrome and reproduction: literature review
  • Monlezun O, Lode-Kolz K, Roulaud M, Paquereau J, Ingrand P, Veyrieras C, Brandet C, Guetarni F, Prévost A, Bataille B, Rigoard P; le groupe Estimet.
    A prospective study evaluating sleep quality in Failed Back Surgery Syndrome patients treated by multicolumn spinal cord stimulation: study design protocol and presentation of the study population.
  • Venisse N, Dupuis A, Badin J, Robert R, Pinsard M, Veinstein A.
    Efficacy and safety of high-dose gentamicin re-dosing in ICU patients receiving haemodialysis.
    J Antimicrob Chemother. 2015 Jan
  • Monlezun O, Voirin J, Roulaud M, Ingrand P, Veyrieras C, Brandet C, Bataille B, Guetarni F, Prevost A, Rigoard P MAST »
    prospective study: value of minimal access spine technologies technique for multicolumn spinal cord stimulation surgical lead implantation in the context of a French multicentre randomized controlled trial (ESTIMET study). »
  • Legendre G, Ringa V, Panjo H, Zins M, Fritel X.
    Incidence and remission of urinary incontinence at midlife: a cohort study.
    BJOG
  • Forestier E, Paccalin M, Roubaud-Baudron C, Fraisse T, Gavazzi G, Gaillat J.
    Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks. 
    Clin Microbiol Infect. 2015 Apr
  • Khiami F, Aziria SA, Ragot S, Pascal-Moussellard H, Richer JP, Scepi M, Brèque C, Hirsch C.
    Reliability and validity of a new measurement of lumbar foraminal volume using a computed tomography.
    Surg Radiol Anat.
  • Osterborg A, Wierda WG, Mayer J, Hess G, Hillmen P, Schetelig J, Schuh A, Smolej L, Beck C, Dreyfus B, Hellman A, Kozlowski P, Pfreundschuh M, Rizzi R, Spacek M, Phillips JL, Gupta IV, Williams V, Jewell RC, Nebot N, Lisby S, Dyer MJ.
    Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.
    Br J Haematol
  • Gahide G, Hadjadj S, Therasse E, Kauffmann C, Gilbert P, Oliva VL, Tardif JC, Lespérance J, Cloutier G, Soulez G.
    Value of C-Arm Computed Tomography to Evaluate Stent Deployment During Femoro-Popliteal Revascularization
    Cardiovasc Intervent Radiol
  • Sutherasan Y, Peñuelas O, Muriel A, Vargas M, Frutos-Vivar F, Brunetti I, Raymondos K, D’Antini D, Nielsen N, Ferguson ND, Böttiger BW, Thille AW, Davies AR, Hurtado J, Rios F, Apezteguía C, Violi DA, Cakar N, González M, Du B, Kuiper MA, Soares MA, Koh Y, Moreno RP, Amin P26, Tomicic V, Soto L, Bülow HH, Anzueto A, Esteban A, Pelosi P; VENTILA GROUP.
    Management and outcome of mechanically ventilated patients after cardiac arrest
    Crit Care
  • Patente TA, Mohammedi K, Bellili-Muñoz N, Driss , Sanchez M, Fumeron F, Roussel R, Hadjadj S, Corrêa-Giannella ML, Marre M, Velho G
    Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Free Radic Biol Med
  • Mohammedi K, Bellili-Muñoz N, Marklund SL, Driss F, Le Nagard H, Patente TA, Fumeron F, Roussel R, Hadjadj S, Marre M, Velho G.
    Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes. 
    Cardiovasc Diabetol.

2014

  • Domenech C, Suciu S, De Moerloose B, Mazingue F, Plat G, Ferster A, Uyttebroeck A, Sirvent N, Lutz P, Yakouben K, Munzer M, Röhrlich P, Plantaz D, Millot F,Philippet P, Dastugue N, Girard S, Cave’ H, Benoit Y, Bertrand Y.
    Dexamethasone (6 mg/m2/d) and prednisolone (60 mg/m2/d) in induction therapy of childhood acute lymphoblastic leukemia are equally effective in EORTC CLG 58951 randomized trial.
    Haemotologica
  • Goede V, Fischer K, Busch R, Engelke A, Eichhorst B, Wendtner CM, Chagorova T, de la Serna J, Dilhuydy MS, Illmer T, Opat S, Owen CJ, Samoylova O, Kreuzer KA, Stilgenbauer S, Döhner H, Langerak AW, Ritgen M, Kneba M, Asikanius E, Humphrey K, Wenger M, Hallek M.
    Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. Patients with CLL and Coexisting Conditions
    NEJM2014 Mar 20;370(12):1101-10. doi: 10.1056/NEJMoa1313984. Epub 2014 Jan 8.
  • – Hughes TP, Hochhaus A, Kantarjian HM, Cervantes F, Guilhot F, Niederwieser D, le Coutre PD, Rosti G, Ossenkoppele G, Lobo C, Shibayama H, Fan X, Menssen HD, Kemp C, Larson RA, Saglio G.
    Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on frontline imatinib or nilotinib 300 mg twice daily.
    Haematologica.2014 Feb 14
  • Hughes TP, Saglio G, Kantarjian HM, Guilhot F, Niederwieser D, Rosti G, Nakaseko C, De Souza CA, Kalaycio ME, Meier S, Fan X, Menssen HD, Larson RA, Hochhaus A.
    Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib.
    Blood 2014 Feb 27;123(9):1353-60. doi: 10.1182/blood-2013-06-510396. Epub 2013 Dec 11
  • Legros L, Guilhot J, Huault S, Mahon FX, Preudhomme C, Guilhot F, Hueber A; from the French CML Group (FI-LMC).
    Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinibLeukemia
    Research 2014 Feb 1. pii: S0145-2126(14)00028-9. doi: 10.1016/j.leukres.2014.01.010. »
  • Pasmant E, Gilbert-Dussardier B, Petit A, de Laval B, Luscan A, Gruber A, Lapillonne H, Deswarte C, Goussard P, Laurendeau I, Uzan B, Pflumio F, Brizard F, Vabres P, Naguibvena I, Fasola S, Millot F, Porteu F, Vidaud D, Landman-Parker J, Ballerini P.
    SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.
    Oncogene.
  • Shah NP, Guilhot F, Cortes JE, Schiffer CA, le Coutre P, Brümmendorf TH, Kantarjian HM, Hochhaus A, Rousselot P, Mohamed H, Healey D, Cunningham M, Saglio G.
    Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study 
    Blood2014 Apr 10;123(15):2317-24. doi: 10.1182/blood-2013-10-532341. Epub 2014 Feb 25.
  • Tranoy-Opalinski I, Legigan T, Barat R, Clarhaut J, Thomas M, Renoux B, Papot S.
    β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update.
    Eur J Med Chem.
  • Betoko A, Charles MA, Hankard R, Forhan A, Bonet M, Regnault N, Botton J, Saurel-Cubizolles MJ, de Lauzon-Guillain B; EDEN Mother-Child Cohort Study Group.
    Determinants of infant formula use and relation with growth in the first 4 months.
    Matern Child Nutr.
  • de Hauteclocque A, Ragot S, Slaoui Y, Gand E, Miot A, Sosner P, Halimi JM, Zaoui P, Rigalleau V, Roussel R, Saulnier PJ, Hadjadj Samy S;
    The SURDIAGENE Study group. The influence of sex on renal function decline in people with Type 2 diabetes.
    Diabet Med.
  • Fava S, Hadjadj S, Walker J
    Diabetic renal disease. Int J Endocrinol.
  • Mohammedi K, Bellili-Muñoz N, Driss F, Roussel R, Seta N, Fumeron F, Hadjadj S, Marre M, Velho G.Manganese
    Superoxide Dismutase (SOD2)
    Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes.
    PLoS One. 2014 May 12;9(5):e96916. doi: 10.1371/journal.pone.0096916. eCollection 2014.
  • Saulnier PJ, Gand E, Ragot S, Ducrocq G, Halimi JM, Hulin-Delmotte C, Llaty P, Montaigne D, Rigalleau V, Roussel R, Velho G, Sosner P, Zaoui P, Hadjadj S; SURDIAGENE Study Group
    Association of Serum Concentration of TNFR1 With All-Cause Mortality in Patients With Type 2 Diabetes and Chronic Kidney Disease: Follow-up of the SURDIAGENE Cohort.
    Diabetes Care2014 May;37(5):1425-31. doi: 10.2337/dc13-2580. Epub 2014 Mar 12
  • Sosner P, Cabasson S, Hulin-Delmotte C, Saulnier PJ, Gand E, Torremocha F, Piguel X, Miot A, Maréchaud R, Herpin D, Ragot S, Hadjadj S; for the SURDIAGENE Study Group.
    Effect of Cornell product and other ECG left ventricular hypertrophy criteria on various cardiovascular endpoints in type 2 diabetic patients.
    Int J Cardiol.2014 Apr 29. pii: S0167-5273(14)00938-3. doi: 10.1016/j.ijcard.2014.04.242.
  • Bauduceau B, Doucet J, Le Floch JP, Verny C; SFD/SFGG Intergroup and the GERODIAB Group.
    Cardiovascular events and geriatric scale scores in elderly (70 years old and above) type 2 diabetic patients at inclusion in the GERODIAB cohort.
    Diabetes Care
  • Welter ML, Schüpbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, Zikos P, Grabli D, Galanaud D, Bonnet AM, Belaid H, Dormont D, Vidailhet M, Mallet L, Houeto JL, Bardinet E, Yelnik J, Agid Y.
    Optimal target localization for subthalamic stimulation in patients with Parkinson disease.
    Neurology
  • Millet B, Jaafari N, Polosan M, Baup N, Giordana B, Haegelen C, Chabardes S, Fontaine D, Devaux B, Yelnik J, Fossati P, Aouizerate B,Krebs MO, Robert G, Jay T, Cornu P, Vérin M, Drapier S, Drapier D, Sauleau P, Peron J, Jeune FL, Naudet F, Reymann JM.
    Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: Accumbens more promising than caudate.
    Eur Neuropsychopharmacol.
  • Defossez G, Rollet A, Dameron O, Ingrand P
    Temporal representation of care trajectories of cancer patients using data from a regional information system: an application in breast cancer
    BMC Med Inform Decis Mak2014 Apr 2;14(1):24. doi: 10.1186/1472-6947-14-24
  • Fournier A, Fritel X, Panjo H, Zins M, Ringa V.
    Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women’s Health Initiative?
    Menopause 2013 Dec 30. [Epub ahead of print]
  • Ragot S, Sosner P, Dievart F, Herpin D.
    Prevalence and management of uncontrolled hypertension in French patients aged over 80 years.
    Arch Cardiovasc Dis.
  • Ramful D, Sampériz S, Fritel X, Michault A, Jaffar-Bandjee MC, Rollot O, Boumahni B, Gérardin P
    Antibody Kinetics in Infants Exposed to Chikungunya Virus Infection During Pregnancy Reveals Absence of Congenital Infection
    J Infect Dis2014 Jan 14. [Epub ahead of print]
  • Savelli M, Boura E, De Luca A, Thomas A, Retaud F, Dupuis Ferber J, Rousseau B, Rauby A, George C, Cugny M, Louis S, Hankard R.
    BMI below the third centile in 4-year-old children
    Archives Pédiatriques2014 May;21(5):544-5. doi: 10.1016/j.arcped.2014.02.017. Epub 2014 Mar 31
  • Sibai MS, Bellarbre F, Ghazali N, Bureau ML, Priner M, Ingrand P, Paccalin M
    Decisional algorithm to prescribe vitamin K antagonist in geriatric patients with atrial fibrillation.
    Geriatr Psychol Neuropsychiatr Vieil.
  • Tripon C, Defossez G, Ragot S, Ghazali A, Boureau-Voultoury A, Scépi M, Oriot D.
    Parental presence during cardiopulmonary resuscitation of children: the experience, opinions and moralpositions of emergency teams in France.
    Arch Dis Child
  • Bridoux A, Thille AW, Quentin S, Lode-Kolz K, Stal V, Diaz V, Brochard L, Drouot X
    Sleep in ICU: atypical sleep or atypical electroencephalography?
    Crit Care Med. 2014  2014 Apr;42(4):e312-3. doi: 10.1097/CCM.0000000000000158.

2013

  • Bachy E, Houot R, Morschhauser F, Sonet A, Brice P, Belhadj K, Cartron G, Audhuy B, Ferme C, Feugier P, Sebban C, Delwail V, Maisonneuve H, Le Gouill S, Lefort S, Brousse N, Foussard C, Salles G.
    Long-term follow-up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma
    Haematologica
  • Narquin S, Ingrand P, Azais I, Delwail V, Vialle R, Boucecbi S, Tasu JP.
    Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Diagn Interv Imaging
  • Clarhaut J, Fraineau S, Guilhot J, Peraudeau E, Tranoy-Opalinski I, Thomas M, Renoux B, Randriamalala E, Bois P, Chatelier A, Monvoisin A, Cronier L, Papot S, Guilhot F.
    A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts
    Leukemia Research
  • Puyade M, Yacoub M, Tomowiak C, Diviné M, Perdrisot R, Guilhot F, Delwail V.
    Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin’s lymphoma
    Acta Haematol 129(4):229-31. doi: 10.1159/000345261. Epub 2013 Jan 11.
  • Marina G. Yefimova,Nadia Messaddeq Thomas Harnois, Annie-Claire Meunier, Jonathan Clarhaut, Anaïs Noblanc,Jean-Luc Weickert, Anne Cantereau, Michel Philippe, Nicolas Bourmeyster, Omar Benzakour
    A chimerical phagocytosis model reveals the recruitment by Sertoli cells of autophagy for the degradation of ingested illegitimate substrates
    Autophagy 2013 May;9(5):653-66. doi: 10.4161/auto.23839. Epub 2013 Feb 25
  • – Millot F, Claviez A, Leverger G, Corbaciglu S, Groll AH, Suttorp M.
    Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase
    Pediatr Blood Cancer 2013 Sep 17. doi: 10.1002/pbc.24521
  • Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators.
    A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias
    N Engl J Med 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494
  • Rousselot P, Cony-Makhoul P, Nicolini F, Mahon FX, Berthou C, Réa D, Reiffers J, Bornand A, Saint-Jean O, Guilhot J,Guilhot F; French Intergroup For Chronic Myelogenous Leukemia (Fi-LMC).
    Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study.
    AM J HEMATOLOL, 2013 Jan;88(1):1-4. doi: 10.1002/ajh.23330. Epub 2012 Sep 17.
  • Guilhot F, Coombs J, Szczudlo T, Zernovak O, Paolantonio M, Bender C, Macdonald NJ, Shapiro A
    The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: qualitative insights using a global ethnographic approach.
    Patient 2013;6(2):81-92. doi: 10.1007/s40271-013-0006-3
  • Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saußele S, Schiffer C, Silver R, Simonsson B, Steegmann JL, Goldman JM, Hehlmann R.
    European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.
    BLOOD 2013 Aug 8;122(6):872-84. doi: 10.1182/blood-2013-05-501569. Epub 2013 Jun 26.
  • Avet-Loiseau H, Hulin C, Campion L, Rodon P, Marit G, Attal M, Royer B, Dib M, Voillat L, Bouscary D, Caillot D, Wetterwald M, Pegourie B, Lepeu G, Corront B, Karlin L, Stoppa AM, Fuzibet JG, Delbrel X, Guilhot F, Kolb B, Decaux O, Lamy T, Garderet L, Allangba O, Lifermann F, Anglaret B, Moreau P, Harousseau JL, Facon T.
    Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience.
    J Clin Oncol 2013 Aug 1;31(22):2806-9. doi: 10.1200/JCO.2012.46.2598. Epub 2013 Jun 24.
  • Grinda M, Legigan T, Clarhaut J, Peraudeau E, Tranoy-Opalinski I, Renoux B, Thomas M, Guilhot F, Papot S.
    An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process
    The Royal Society of Chemistry 2013 2013 Nov 7;11(41):7129-33. doi: 10.1039/c3ob41536h
  • Johnson-Ansah H, Guilhot J, Rousselot P, Rea D, Legros L, Rigal-Huguet F, Nicolini FE, Mahon FX, Preudhomme C,Guilhot F.
    Tolerability and efficacy of pegylated interferon-a-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia.
    Cancer. 2013 Dec 15;119(24):4284-9. doi: 10.1002/cncr.28328. Epub 2013 Sep 16.
  • Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F.
    International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.
    Qual Life Res. 2013 Sep 13. [Epub ahead of print]
  • Rodrigues CA, Rocha V, Dreger P, Brunstein CG, Sengeloev H, Finke J, Mohty M, Rio B, Petersen E, Guilhot F, Niederwieser D, Cornelissen JJ, Jindra P, Nagler A, Fegueux N, Schoemans H, Robinson S, Ruggeri A, Gluckman E, Canals C, Sureda A.
    Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood.
    Haematologica. 2013 Aug 9. [Epub ahead of print]
  • Hebraud B, Leleu X, Lauwers-Cances V, Roussel M, Caillot D, Marit G, Karlin L, Hulin C, Gentil C, Guilhot F, Garderet L, Lamy T, Brechignac S, Pegourie B, Jaubert J, Dib M, Stoppa AM, Sebban C, Fohrer C, Fontan J, Fruchart C, Macro M, Orsini-Piocelle F, Lepeu G, Sohn C, Corre J, Facon T, Moreau P, Attal M, Avet-Loiseau H.
    Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.
    Leukemia. 2013 Jul 29. doi: 10.1038/leu.2013.225. [Epub ahead of print]
  • Rousselot P, Charbonnier A, Cony-Makhoul P, Agape P, Nicolini FE, Varet B, Gardembas M, Etienne G, Réa D, Roy L, Escoffre-Barbe M, Guerci-Bresler A, Tulliez M, Prost S, Spentchian M, Cayuela JM, Reiffers J, Chomel JC, Turhan A,Guilhot J, Guilhot F, Mahon FX.
    Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease
    J Clin Oncol 2013 Dec 9. [Epub ahead of print]
  • Tea I, Le Guennec A, Frasquet-Darrieux M, Julien M, Romek K, Antheaume I, Hankard R, Robins RJ.
    Simultaneous determination of natural-abundance d(15) N values and quantities of individual amino acids in proteins from milk of lactating women and from infant hair using gas chromatography/isotope ratio mass spectrometry.
    Rapid Commun Mass Spectrom
  • de Luca A, Parizel A, Fromont G, Roblot P, Roblot F, Gambert-Abdel Rahman C, Hankard R
    High procalcitonin and thrombocytopenic purpura in a case of Kikuchi-Fujimoto disease.
    Arch Pediatr 2013 Jun 11. pii: S0929-693X(13)00294-7. doi: 10.1016/j.arcped.2013.04.016.
  • Mohammedi K, Patente TA, Bellili-Muñoz N, Driss F, Monteiro MB, Roussel R, Pavin EJ, Seta N, Fumeron F, Azevedo MJ, Canani LH, Hadjadj S, Marre M, Corrêa-Giannella ML, Velho G
    Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes.
    Diabetologia 2013 Dec;56(12):2733-42. doi: 10.1007/s00125-013-3057-z.
  • Bonnefond A, Saulnier PJ, Stathopoulou MG, Grarup N, Ndiaye NC, Roussel R, Nezhad MA, Dechaume A, Lantieri O, Hercberg S, Lauritzen T, Balkau B, El-Sayed Moustafa JS, Hansen T, Pedersen O, Froguel P, Charpentier G, Marre M,Hadjadj S, Visvikis-Siest S.
    What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
    PLOS ONE 2013;8(2):e55921. doi: 10.1371/journal.pone.0055921
  • Roussel R, Hadjadj S, Pasquet B, Wilson PW, Smith SC Jr, Goto S, Tubach F, Marre M, Porath A, Krempf M, Bhatt DL, Steg PG.
    Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
    Int J Cardiol 2013 Aug 20;167(4):1380-4. doi: 10.1016/j.ijcard.2012.04.019.
  • Burbaud P, Clair AH, Langbour N, Fernandez-Vidal S, Goillandeau M, Michelet T, Bardinet E, Chéreau I, Durif F, Polosan M, Chabardès S, Fontaine D, Magnié-Mauro MN, Houeto JL, Bataille B, Millet B, Vérin M, Baup N, Krebs MO, Cornu P, Pelissolo A, Arbus C, Simonetta-Moreau M, Yelnik J, Welter ML, Mallet L; French Stimulation dans le Trouble Obsessionnel Compulsif Study Group.
    Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder
    Brain
  • Rotge JY, Langbour N, Dilharreguy B, Bordessoulles M, Guehl D, Bioulac B, Martin-Guehl C, Jaafari N, Aouizerate B, Allard M, Burbaud P.
    Contextual and behavioral influences on uncertainty in obsessive-compulsive disorder.
    CORTEX
  • Millet B, Dondaine T, Reymann JM, Bourguignon A, Naudet F, Jaafari N, Drapier D, Turmel V, Mesbah H, Vérin M, Le Jeune F.
    Obsessive compulsive disorder networks: positron emission tomography and neuropsychology provide new insights.
    PLoS One. 2013;8(1):e53241. doi: 10.1371/journal.pone.0053241. Epub 2013 Jan 11.
  • Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, Jaafari N, Schischmanoff O, Fagard R, Lagdas E, Kermarrec S, Ribardiere S, Botbol M, Fougerou C, Bronsard G, Vernay-Leconte J.
    Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives
    Int J Mol Sci 2013 Oct 14;14(10):20508-42. doi: 10.3390/ijms141020508
  • Velho G, Bouby N, Hadjadj S, Matallah N, Mohammedi K, Fumeron F, Potier L, Bellili-Munoz N, Taveau C, Alhenc-Gelas F, Bankir L, Marre M, Roussel R.
    Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria.
    Diabetes Care
  • Fritel X, Lachal L, Cassou B, Fauconnier A, Dargent-Molina P.
    Mobility impairment is associated with urge but not stress urinary incontinence in community-dwelling older women: results from the Ossébo study.
    BJOG 2013 Jun 10. doi: 10.1111/1471-0528.12316.
  • Javaugue V, Karras A, Glowacki F, McGregor B, Lacombe C, Goujon JM, Ragot S, Aucouturier P, Touchard G, Bridoux F.
    Long-term Kidney Disease Outcomes in Fibrillary Glomerulonephritis: A Case Series of 27 Patients
    Am J Kidney Dis 2013 Jun 4. pii: S0272-6386(13)00714-2. doi: 10.1053/j.ajkd.2013.03.031.
  • Gavazzi G, Delerce E, Cambau E, François P, Corroyer B, de Wazières B, Fougère B, Paccalin M, Gaillat J.
    Diagnostic criteria for urinary tract infection in hospitalized elderly patients over 75 years of age: A multicenter cross-sectional study.
    Médecine et maladies infectieuses
  • Marret H, Fernandez H, Fritel X, Herbreteau D.
    Myoma management: New guidelines
    La presse médicale
  • Jouhet V, Defossez G; CRISAP; CoRIM, Ingrand P.
    Automated Selection of Relevant Information for Notification of Incident Cancer Cases within a Multisource Cancer Registry.
    Methods Inf Med
  • Lucot JP, Fritel X, Debodinance P, Bader G, Cosson M, Giraudet G, Collinet P, Rubod C, Fernandez H, Fournet S, Lesavre M, Deffieux X, Faivre E, Trichot C, Demoulin G, Jacquetin B, Savary D, Botchorichvili R, Campagne Loiseau S, Salet-Lizee D, Villet R, Gadonneix P, Delporte P, Ferry P, Aucouturier JS, Thirouard Y, de Tayrac R, Fatton B, Wagner L, Nadeau C, Wattiez A, Garbin O, Youssef Azer Akladios C, Thoma V, Baulon Thaveau E, Saussine C, Hermieu JF, Delmas V, Blanc S, Tardif D, Fauconnier A; GROG (groupe de recherche en gynécologie et obstétrique).
    PROSPERE randomized controlled trial: Laparoscopic sacropexy versus vaginal mesh for cystocele POP repair
    journal gynecologie obstétrique
  • Efficacy and safety of pegylated-interferon a-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups
    Br J Haematol 2013 Sep;162(6):783-91. doi: 10.1111/bjh.12459. Epub 2013 Jul 13.
  • Ansquer S, Belin-Rauscent A, Dugast E, Duran T, Benatru I, Mar AC, Houeto JL, Belin D.
    Atomoxetine Decreases Vulnerability to Develop Compulsivity in High Impulsive Rats.
    Biol Psychiatry 2013 Oct 11. pii: S0006-3223(13)00904-9. doi: 10.1016/j.biopsych.2013.09.031. [Epub ahead of print]
  • – Mimoun C, Fritel X, Fauconnier A, Deffieux X, Dumont A, Huchon C.
    Épidémiologie des tumeurs ovariennes présumées bénignes
  • – Desseauve D, Pierre F, Fritel X.
    Urinary incontinence in women: study of surgical practice in France.
    Prog Urol. 2013 Apr;23(4):249-55. doi: 10.1016/j.purol.2012.12.005
  • Fritel X, Khoshnood B, Fauconnier A.
    Specific obstetrical risk factors for urinary versus anal incontinence 4years after first delivery.
    Prog Urol. 2013 Sep;23(11):911-6. doi: 10.1016/j.purol.2013.06.009
  • Testefort A, Giraudeau B, Lamireau T, Tounian P, Dubus JC, Chabrol B, Bader-Meunier B, Hankard R
    Evaluation of the abstracts submitted to the French Society of Pediatrics (SFP) in 2012
    Arch Pediatr 2013 Mar;20(3):315-6. doi: 10.1016/j.arcped.2012.12.022.
  • Hankard R, Tounian P, Chabrol B.
    Research: a priority for the French Society of Pediatrics (SFP)
    Arch Pediatr 2013 Mar;20(3):217-8. doi: 10.1016/j.arcped.2012.12.018.
  • Auner HW, Szydlo R, van Biezen A, Iacobelli S, Gahrton G, Milpied N, Volin L, Janssen J, Nguyen Quoc S, Michallet M, Schoemans H, El Cheikh J, Petersen E, Guilhot F, Schönland S, Ahlberg L, Morris C, Garderet L, de Witte T, Kröger N.
    Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation.
    Bone Marrow Transplant 2013 Nov;48(11):1395-400. doi: 10.1038/bmt.2013.73. Epub 2013 May 27.
  • Fritel X, Dumoulin C.
    Incontinence: Stress urinary incontinence treatment-surgery first?
    Nat Rev Urol. 2013 Dec 10. doi: 10.1038/nrurol.2013.300.
  • Fritel X, Panjo H, Varnoux N, Ringa V.
    The individual determinants of care-seeking among middle-aged women reporting urinary incontinence: Analysis of a 2273-woman cohort.
    Neurourol Urodyn 2013 Jul 1. doi: 10.1002/nau.22461.
  • Brun JL, Fritel X, Levêque J.
    Clinical practice guidelines: Presumed benign ovarian tumors – Aims, methods, and organization.
    J Gynecol Obstet Biol Reprod (Paris). 2013 Dec;42(8):710-4. doi: 10.1016/j.jgyn.2013.09.025.
  • Billecocq S, Morel MP, Fritel X.
    Levator ani trauma after childbirth, from stretch injury to avulsion: review of the literature.
    Prog Urol 2013 Jun;23(8):511-8. doi: 10.1016/j.purol.2013.04.003.
  • Pizzoferrato AC, Fauconnier A, Quiboeuf E, Morel K, Schaal JP, Fritel X.
    Urinary incontinence 4 and 12 years after first delivery: Risk factors associated with prevalence, incidence, remission, and persistence in a cohort of 236 women.
    Neurourol Urodyn 2013 Oct 16. doi: 10.1002/nau.22498.
  • Fritel X, Fauconnier A.
    Does the SWEPOP (Swedish Pregnancy, Obesity and Pelvic Floor) study suffer from a selection bias?
    BJOG. 2013 Nov;120(12):1578-9. doi: 10.1111/1471-0528.12417.

2012

  • Bonnefond A, Clément N, Fawcett K, Yengo L, Vaillant E, Guillaume JL, Dechaume A, Payne F, Roussel R, Czernichow S, Hercberg S, Hadjadj S, Balkau B, Marre M, Lantieri O, Langenberg C, Bouatia-Naji N; The Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC), Charpentier G, Vaxillaire M, Rocheleau G, Wareham NJ, Sladek R, McCarthy MI, Dina C, Barroso I, Jockers R, Froguel P.
    Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.
    Nat Genet2012 Jan 29;44(3):297-301
  • Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D
    Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
    Lancet Neurol2012 Jul;11(7):589-96
  • Legigan T, Clarhaut J, Tranoy-Opalinski I, Monvoisin A, Renoux B, Thomas M, Le Pape A, Lerondel S, Papot S.
    The First Generation of ß-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy.
    Angew Chem Int Ed Engl2012 Nov 12;51(46):11606-10
  • Robert R, Reignier J, Tournoux-Facon C, Boulain T, Lesieur O, Gissot V, Souday V, Hamrouni M, Chapon C, Gouello JP; Association des Réanimateurs du Centre Ouest Group.
    Refusal of intensive care unit admission due to a full unit: impact on mortality
    Am J Respir Crit Care Med. 2012 May 15;185(10):1081-72012 May 15;185(10):1081-7
  • Czuczman MS, Fayad L, Delwail V, Cartron G, Jacobsen E, Kuliczkowski K, Link BK, Pinter-Brown L, Radford J, Hellmann A, Gallop-Evans E, DiRienzo CG, Goldstein N, Gupta I, Jewell RC, Lin TS, Lisby S, Schultz M, Russell CA, Hagenbeek A; 405 Study Investigators.
    Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.
    Blood2012 Apr 19;119(16):3698-704
  • Guilhot J, Baccarani M, Clark RE, Cervantes F, Guilhot F, Hochhaus A, Kulikov S, Mayer J, Petzer AL, Rosti G, Rousselot P, Saglio G, Saussele S, Simonsson B, Steegmann JL, Zaritskey A, Hehlmann R.
    Definitions, methodological, and statistical issues for phase III clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.
    Blood2012 Jun 21;119(25):5963-71
  • Chomel JC, Sorel N, Guilhot J, Guilhot F, Turhan AG.
    BCR-ABL expression in leukemic progenitors and primitive stem cells of patients with chronic myeloid leukemia.
    Blood2012 Mar 22;119(12):2964-5; author reply 2965-6
  • Hoffmann V, Baccarani M, Hasford J, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R.
    The EUTOS CML score aims to support clinical decision-making
    Blood2012 Mar 22;119(12):2966-7.
  • Fraineau S, Monvoisin A, Clarhaut J, Talbot J, Simonneau C, Kanthou C, Kanse SM, Philippe M, Benzakour O.
    The vitamin K-dependent anti-coagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner.
    Blood2012 Dec 13;120(25):5073-83
  • Rea D, Etienne G, Nicolini F, Cony-Makhoul P, Johnson-Ansah H, Legros L, Huguet F, Tulliez M, Gardembas M, Bouabdallah K, Rousselot P, Cayuela JM, Guilhot F, Mahon FX.
    First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia.
    Leukemia2012 Oct;26(10):2254-9
  • Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Mäkinen VP, Swan EJ, Palmer C, Boright AP, Ahlqvist E, Deshmukh HA, Keller BJ, Huang H, Ahola AJ, Fagerholm E, Gordin D, Harjutsalo V, He B, Heikkilä O, Hietala K, Kytö J, Lahermo P, Lehto M, Lithovius R, Osterholm AM, Parkkonen M, Pitkäniemi J, Rosengård-Bärlund M, Saraheimo M, Sarti C, Söderlund J, Soro-Paavonen A, Syreeni A, Thorn LM, Tikkanen H, Tolonen N, Tryggvason K, Tuomilehto J, Wadén J, Gill GV, Prior S, Guiducci C, Mirel DB, Taylor A, Hosseini SM; DCCT/EDIC Research Group, Parving HH, Rossing P, Tarnow L, Ladenvall C, Alhenc-Gelas F, Lefebvre P, Rigalleau V, Roussel R, Tregouet DA, Maestroni A, Maestroni S, Falhammar H, Gu T, Möllsten A, Cimponeriu D, Ioana M, Mota M, Mota E, Serafinceanu C, Stavarachi M, Hanson RL, Nelson RG, Kretzler M, Colhoun HM, Panduru NM, Gu HF, Brismar K, Zerbini G, Hadjadj S, Marre M, Groop L, Lajer M, Bull SB, Waggott D, Paterson AD, Savage DA, Bain SC, Martin F, Hirschhorn JN, Godson C, Florez JC, Groop PH, Maxwell AP.
    New susceptibility Loci associated with kidney disease in type 1 diabetes.
    PLoS Genet. 2012 Sep;8(9):e1002921
  • Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikäinen LP, Fuchsberger C, Tanaka T, Morris AP, Small K, Isaacs A, Beekman M, Coassin S, Lohman K, Qi L, Kanoni S, Pankow JS, Uh HW, Wu Y, Bidulescu A, Rasmussen-Torvik LJ, Greenwood CM, Ladouceur M, Grimsby J, Manning AK, Liu CT, Kooner J, Mooser VE, Vollenweider P, Kapur KA, Chambers J, Wareham NJ, Langenberg C, Frants R, Willems-Vandijk K, Oostra BA, Willems SM, Lamina C, Winkler TW, Psaty BM, Tracy RP, Brody J, Chen I, Viikari J, Kähönen M, Pramstaller PP, Evans DM, St Pourcain B, Sattar N, Wood AR, Bandinelli S, Carlson OD, Egan JM, Böhringer S, van Heemst D, Kedenko L, Kristiansson K, Nuotio ML, Loo BM, Harris T, Garcia M, Kanaya A, Haun M, Klopp N, Wichmann HE, Deloukas P, Katsareli E, Couper DJ, Duncan BB, Kloppenburg M, Adair LS, Borja JB; DIAGRAM+ Consortium; MAGIC Consortium; GLGC Investigators; MuTHER Consortium, Wilson JG, Musani S, Guo X, Johnson T, Semple R, Teslovich TM, Allison MA, Redline S, Buxbaum SG, Mohlke KL, Meulenbelt I, Ballantyne CM, Dedoussis GV, Hu FB, Liu Y, Paulweber B, Spector TD, Slagboom PE, Ferrucci L, Jula A, Perola M, Raitakari O, Florez JC, Salomaa V, Eriksson JG, Frayling TM, Hicks AA, Lehtimäki T, Smith GD, Siscovick DS, Kronenberg F, van Duijn C, Loos RJ, Waterworth DM, Meigs JB, Dupuis J, Richards JB, Voight BF, Scott LJ, Steinthorsdottir V, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Hofmann OM, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Boström KB, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jørgensen T, Kao WH, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Petersen AK, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsø T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Morris AD, Palmer CN, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Pedersen O, Barroso I, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI, Soranzo N, Wheeler E, Glazer NL, Bouatia-Naji N, Mägi R, Randall J, Elliott P, Rybin D, Dehghan A, Hottenga JJ, Song K, Goel A, Lajunen T, Doney A, Cavalcanti-Proença C, Kumari M, Timpson NJ, Zabena C, Ingelsson E, An P, O’Connell J, Luan J, Elliott A, McCarroll SA, Roccasecca RM, Pattou F, Sethupathy P, Ariyurek Y, Barter P, Beilby JP, Ben-Shlomo Y, Bergmann S, Bochud M, Bonnefond A, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Crisponi L, Day IN, de Geus EJ, Delplanque J, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Grundy S, Gwilliam R, Hallmans G, Hammond N, Han X, Hartikainen AL, Hayward C, Heath SC, Hercberg S, Hillman DR, Hingorani AD, Hui J, Hung J, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Mahley R, Mangino M, Martínez-Larrad MT, McAteer JB, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Mukherjee S, Naitza S, Neville MJ, Orrù M, Pakyz R, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Seedorf U, Sharp SJ, Shields B, Sigurðsson G, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvänen AC, Tönjes A, Uitterlinden AG, van Dijk KW, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Ward KL, Watkins H, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC; DIAGRAM Consortium; GIANT Consortium; Global B Pgen Consortium, Borecki IB, Meneton P, Magnusson PK, Nathan DM, Williams GH, Silander K, Bornstein SR, Schwarz P, Spranger J, Karpe F, Shuldiner AR, Cooper C, Serrano-Ríos M, Lind L, Palmer LJ, Hu FB 1st, Franks PW, Ebrahim S, Marmot M, Kao WH, Pramstaller PP, Wright AF, Stumvoll M, Hamsten A; Procardis Consortium, Buchanan TA, Valle TT, Rotter JI, Penninx BW, Boomsma DI, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Peltonen L, Mooser V, Sladek R; MAGIC investigators; GLGC Consortium, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Chasman DI, Johansen CT, Fouchier SW, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Feitosa MF, Orho-Melander M, Melander O, Li X, Li M, Cho YS, Go MJ, Kim YJ, Lee JY, Park T, Kim K, Sim X, Ong RT, Croteau-Chonka DC, Lange LA, Smith JD, Ziegler A, Zhang W, Zee RY, Whitfield JB, Thompson JR, Surakka I, Spector TD, Smit JH, Sinisalo J, Scott J, Saharinen J, Sabatti C, Rose LM, Roberts R, Rieder M, Parker AN, Pare G, O’Donnell CJ, Nieminen MS, Nickerson DA, Montgomery GW, McArdle W, Masson D, Martin NG, Marroni F, Lucas G, Luben R, Lokki ML, Lettre G, Launer LJ, Lakatta EG, Laaksonen R, Kyvik KO, König IR, Khaw KT, Kaplan LM, Johansson Å, Janssens AC, Igl W, Hovingh GK, Hengstenberg C, Havulinna AS, Hastie ND, Harris TB, Haritunians T, Hall AS, Groop LC, Gonzalez E, Freimer NB, Erdmann J, Ejebe KG, Döring A, Dominiczak AF, Demissie S, Deloukas P, de Faire U, Crawford G, Chen YD, Caulfield MJ, Boekholdt SM, Assimes TL, Quertermous T, Seielstad M, Wong TY, Tai ES, Feranil AB, Kuzawa CW, Taylor HA Jr, Gabriel SB, Holm H, Gudnason V, Krauss RM, Ordovas JM, Munroe PB, Kooner JS, Tall AR, Hegele RA, Kastelein JJ, Schadt EE, Strachan DP, Reilly MP, Samani NJ, Schunkert H, Cupples LA, Sandhu MS, Ridker PM, Rader DJ, Kathiresan S.
    Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
    PLoS Genet.2012;8(3):e1002607
  • Perry JR, Voight BF, Yengo L, Amin N, Dupuis J, Ganser M, Grallert H, Navarro P, Li M, Qi L, Steinthorsdottir V, Scott RA, Almgren P, Arking DE, Aulchenko Y, Balkau B, Benediktsson R, Bergman RN, Boerwinkle E,Bonnycastle L, Burtt NP, Campbell H, Charpentier G, Collins FS, Gieger C, Green T,  Hadjadj S, Hattersley AT,Herder C, Hofman A, Johnson AD, Kottgen A, Kraft P, Labrune Y, Langenberg C, Manning AK, Mohlke KL,Morris AP, Oostra B, Pankow J, Petersen AK, Pramstaller PP, Prokopenko I, Rathmann W, Rayner W, Roden M, Rudan I, Rybin D, Scott LJ, Sigurdsson G, Sladek R, Thorleifsson G, Thorsteinsdottir U, Tuomilehto J,Uitterlinden AG, Vivequin S, Weedon MN, Wright AF; MAGIC; DIAGRAM Consortium; GIANT Consortium, Hu FB, Illig T, Kao L, Meigs JB, Wilson JF, Stefansson K, van Duijn C, Altschuler D, Morris AD, Boehnke M,McCarthy MI, Froguel P, Palmer CN, Wareham NJ, Groop L, Frayling TM, Cauchi S.
    Stratifying Type 2 Diabetes Cases by BMI Identifies Genetic Risk Variants in LAMA1 and Enrichment for Risk Variants in Lean Compared to Obese Cases
    PLoS Genet.2012 May;8(5):e1002741
  • Miot A, Ragot S, Hammi W, Saulnier PJ, Sosner P, Piguel X, Torremocha F, Marechaud R, Hadjadj S
    Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients: A competing risk analysis in a prospective cohort.
    Diabetes Care2012 Oct;35(10):2069-75. Epub 2012 Jul 18.
  • Bonnefond A, Yengo L, Philippe J, Dechaume A, Ezzidi I, Vaillant E, Gjesing AP, Andersson EA, Czernichow S, Hercberg S,  Hadjadj S, Charpentier G, Lantieri O,Balkau B, Marre M, Pedersen O, Hansen T, Froguel P, Vaxillaire M.
    Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes.
    Diabetologia2012 Dec 6. [Epub ahead of print]
  • D. Montaigne, O. Bailloeuil, C. Hulin-Delmotte, J.L. Edme, P. Sosner, A. Miot, S. Ragot, P.J. Saulnier, O. Dupuy, P. Gourdy, P. Lecomte, B. Guerci, D. Dardari, R. Roussel, R. Neviere, D. Lacroix, S. Hadjadj, on behalf of the DIAB2NEPHROGENE and SURDIAGENE study groups
    Renal complications correlate with electrical atrial vulnerability hallmarks in type 2 diabetic patients
    International Journal of Cardiology2012 Aug 9;159(1):63-6.
  • Gaud MA, Frasquet-Darrieux M, Ingrand P, Hankard R, Glomot F, Christin P, Compain F, Bucco C, Pierre F.
    Gestational weight gain: arguments for a transgenerational weight-control process.
    Am J Clin Nutr2012 Feb;95(2):529; author reply 529-31
  • Tang M, Foo J, Gonen M, Guilhot J, Mahon FX, Michor F.
    Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials.
    Haematologica2012 Oct;97(10):1553-61
  • Guilhot F, Hughes TP, Cortes J, Druker BJ, Baccarani M, Gathmann I, Hayes M, Granvil C, Wang Y.
    Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial.
    Haematologica. 2012 May;97(5):731-8.
  • Jaafari N, de la Cruz LF, Grau M, Knowles E, Radua J, Wooderson S, Segalas C, Alonso P, Phillips ML, Menchón JM, Mataix-Cols D.
    Neurological soft signs in obsessive-compulsive disorder: two empirical studies and meta-analysis.
    Psychol Med. 2012 Aug 30:1-11.
  • Rochelle T, Daubon T, Van Troys M, Harnois T, Waterschoot D, Ampe C, Roy L, Bourmeyster N, Constantin B.
    p210bcr-abl induces amoeboid motility by recruiting ADF/destrin through RhoA/ROCK1.
    FASEB J2012 Oct 9. [Epub ahead of print]
  • Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Berjeaud JM, Guilhot F, Papot S.
    Synthesis and Antitumor Efficacy of a a-Glucuronidase-Responsive Albumin-Binding Prodrug of Doxorubicin.
    J Med Chem.2012 May 10;55(9):4516-20.
  • Guilhot F, Roy L, Tomowiak C.
    Current treatment strategies in chronic myeloid leukemia.
    Curr Opin Hematol.2012 Mar;19(2):102-9
  • Couturier J, Paccalin M, Lafay-Chebassier C, Chalon S, Ingrand I, Pinguet J, Pontcharraud R, Guillard O, Fauconneau B, Page G
    Pharmacological inhibition of the double-stranded RNA-dependent protein kinase prevents long-term inflammation in APPswePS1dE9 mice but increases amyloid burden at advanced stages of Alzheimer’s disease
    Current Alzheimer Research2012 Mar;9(3):344-60
  • Rossignol A, Levescot A, Jacomet F, Robin A, Basbous S, Giraud C, Roy L, Guilhot F, Turhan AG, Barra A, Herbelin A, Gombert JM.
    Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
    Eur J Immunol2012 Jul;42(7):1870-5
  • Landré L, Destrieux C, Andersson F, Barantin L, Quidé Y, Tapia G, Jaafari N, Clarys D, Gaillard P, Isingrini M, El-Hage W.
    Working memory processing of traumatic material in women with posttraumatic stress disorder.
    J Psychiatry Neurosci2012 Feb;37(2):87-94
  • Tchang JH, Paik SY, Mao L, Eisner W, Flannery PJ, Wang L, Tang Y, Mattocks N, Hadjadj S, Goujon JM, Ruiz P, Gurley SB, Spurney RF.
    Diabetic Kidney Disease in FVB/NJ Akita Mice: Temporal Pattern of Kidney Injury and Urinary Nephrin Excretion
    PLoS One2012;7(4):e33942
  • Palmer ND, McDonough CW, Hadjadj S, Hicks PJ, Roh BH, Wing MR, An SS, Hester JM, Cooke JN
    A genome-wide association search for type 2 diabetes genes in African Americans.
    PLoS One2012;7(1):e29202
  • Arroyo-Anlló EM, Bellouard S, Ingrand P, Gil R.
    Effects of Automatic/Controlled Access Processes on Semantic Memory in Alzheimer’s Disease
    J Alzheimers Dis2011;25(3):525-33
  • Lamiche C, Clarhaut J, Strale PO, Crespin S, Pedretti N, Bernard FX, Naus CC, Chen VC, Foster LJ, Defamie N, Mesnil M, Debiais F, Cronier L.
    The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells.
    Clin Exp Metastasis.2012 Feb;29(2):111-22
  • Letellier G, Mok E, Alberti C, De Luca A, Gottrand F, Cuisset JM, Denjean A, Darmaun D, Hankard R.
    Effect of glutamine on glucose metabolism in children with Duchenne muscular dystrophy.
    Clin Nutr. 2012 Sep 14. pii: S0261-5614(12)00186-0
  • Strale PO, Clarhaut J, Lamiche C, Cronier L, Mesnil M, Defamie N.
    Down-regulation of connexin43 expression reveals the involvement of caveolin-1 containing lipid rafts in human U251 glioblastoma cell invasion.
    Mol Carcinog2012 Nov;51(11):845-60
  • de Luca A, Boisseau N, Tea I, Louvet I, Robins RJ, Forhan A, Charles MA, Hankard R.
    d(15)N and d(13)C in hair from newborn infants and their mothers: a cohort study.
    Pediatr Res.2012 May;71(5):598-604
  • Legendre G, Ringa V, Fauconnier A, Fritel X.
    Menopause, hormone treatment and urinary incontinence at midlife.
    Maturitas2013 Jan;74(1):26-30
  • Gater A, Heron L, Abetz-Webb L, Coombs J, Simmons J, Guilhot F, Rea D.
    Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia.
    Leuk Res2012 Jul;36(7):817-25
  • Ingrand I, Houeto JL, Gil R, Mc Gee H, Ingrand P, Paccalin M.
    The validation of a French-language version of the Aging Perceptions Questionnaire (APQ) and its extension to a population aged 55 and over.
    BMC Geriatr.2012 Apr 30;12:17
  • Bloch F, Thibaud M, Tournoux-Facon C, Brèque C, Rigaud AS, Dugué B, Kemoun G.
    Estimation of the risk factors for falls in the elderly: Can meta-analysis provide a valid answer?
    GERIATR GERONTOL INT2012 Nov 27.
  • Oriot D, Darrieux E, Boureau-Voultoury A, Ragot S, Scépi M.
    Validation of a Performance Assessment Scale for Simulated Intraosseous Access.
    Simul Healthc2012 Jun;7(3):171-5
  • Tournoux-Facon C, Robinet G, Pinel MC, Ferre P, Tourani JM.
    Phase I and Pharmacokinetic Study of IV Vinflunine in Combination With Carboplatin in Chemonaive Patients With Advanced Non-small Cell Lung Cancer.
    J Clin Oncol. 2012 Aug;35(4):378-85
  • Fritel X, Ringa V, Quiboeuf E, Fauconnier A.
    Female urinary incontinence, from pregnancy to menopause: a review of epidemiological and pathophysiological findings
    Acta Obstet Gynecol Scand.2012 Aug;91(8):901-10
  • Mathis S, Dupuis-Girod S, Plauchu H, Giroud M, Barroso B, Ly KH, Ingrand P, Gilbert B, Godenèche G, Neau JP.
    Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation.
    Clin Neurol Neurosurg.2012 Apr;114(3):235-40
  • Frédéric K, Cyril B, Hugues PM, Stéphanie R, Caroline H, Jean Pierre R, Michel S.
    Intervertebral Foramen Variation Following Dynamic L4-L5 Interspinal Device Implantation: Foramen Size After Interspinal Device Implantation.
    J Spinal Disord Tech2012 Nov 22. [Epub ahead of print]
  • Souviat C, Bricou A, Porcher R, Demaria F, Fritel X, Benifla JL, Pigné A.
    Long-term functional stability of sacrospinous ligament-fixation repair of pelvic organ prolapse.
    J Obstet Gynaecol2012 Nov;32(8):781-5.
  • De Luca A, Piloquet H, Mansilla M, Simon D, Fischbach M, Caldari D, Dorigny B, Ingrand P, Hankard R.
    Multicenter nutritional screening in hospitalized children.
    Arch Pediatr2012 May;19(5):545-6
  • D. Montaigne, O. Bailloeuil, C. Hulin-Delmotte, J.L. Edme, P. Sosner, A. Miot, S. Ragot, P.J. Saulnier, O. Dupuy, P. Gourdy, P. Lecomte, B. Guerci, D. Dardari, R. Roussel, R. Neviere, D. Lacroix, S. Hadjadj, on behalf of the DIAB2NEPHROGENE and SURDIAGENE study groups
    Renal complications correlate with electrical atrial vulnerability hallmarks in type 2 diabetic patientsInternational 
    SFD 2012 Nice France
  • PJ Saulnier Y Gallois, S Ragot, P Gourdy, F Bonnet, G Charpentier, O Dupuy,B Guerci, G Guilloteau, P Lecomte, F Rachedi1 R Roussel, A Sechet O Verier-Mine, M Marre, R Marechaud, S Hadjadj for the DIAB2NEPHROGENE study group.
    Impact of sex hormones and of aromatase gene variants on diabetic nephropathy in type 2 diabetes.
    EDNSG meeting 2012 Dublin Ireland
  • Miot, A; Ragot, S ; Hammi, W ; Saulnier, PJ; Sosner, P ; Piguel, X ; Marechaud, R; Hadjadj, S
    Prognostic value of cardiac frequency in cardiovascular and renal risk events in type 2 diabetic patients: prospective study.
    SFD 2012 Nice France
  • Quiboeuf E, Saurel MJ, Fritel X.
    Evolution of urinary incontinence in women between 4 and 24 months postpartum in the cohort EDEN. 
    ICS 2012, Beijing, China.
  • Quiboeuf E, Saurel MJ, Fritel X.
    Evolution de l’incontinence urinaire chez la femme entre 4 et 24 mois post-partum dans la cohorte EDEN.
    SIFUD-PP 2012, Clermont-Ferrand, France.
  • Fritel X, Fauconnier A, Savary D, Letouzey V, Gueye A, Campagne S, Bader G, Cotte L, Fianu A, Fernandez H, Guilhot-Gaudeffroy J, de Tayrac R.
    Prevent postnatal urinary incontinence by prenatal pelvic floor muscle training? First results of the multicenter randomized study 3PN, PreNatal Pelvic floor Prevention. 
    ICS 2012, Beijing, China.
  • Fritel X, Fauconnier A, Savary D, Letouzey V, Gueye A, Campagne S, Bader G, Deffieux X, Cotte L, Richet C, Fianu A, Fernandez H, Guilhot-Gaudeffroy J, de Tayrac R.
    Prévenir l’incontinence urinaire postnatale par la rééducation périnéale prénatale ? Premiers résultats de l’étude randomisée multicentrique 3PN, Prévention Périnéale PréNatale.
    SIFUD-PP 2012, Clermont-Ferrand, France.
  • Rea D, Rousselot P, Guilhot J, Guilhot F, Mahon FX.
    Curing chronic myeloid leukemia.
    Curr Hematol Malig Rep.2012 Jun;7(2):103-8.
  • Baudemont C, Merlet I, Boisgueheneuc FD, Liuu E, Tartarin F,  Ragot S,  Paccalin M.
    Cognitive-behavioral specialized units: predictive factors of readmissions within three months.
    Geriatr Psychol Neuropsychiatr Vieil. 2012 Sep 1;10(3):277-283.
  • M Grinda, J Clarhaut, B Renoux, I Tranoy-Opalinskia, S Papot
    A self-immolative dendritic glucuronide prodrug of doxorubicinMed. 
    Chem. Commun

[:]